Selected Publications

Patterson AV, Talbot DC, Stratford IJ and Harris AL. Thymidine Phosphorylase moderates thymidine-dependent rescue after exposure to the thymidine synthase inhibitor ZD1694 (Tomudex) in vitro. Cancer Res. 1998; 58: 2737-2740.

Miller SJ, HopeT, Talbot DC. The development of a structured rating schedule (the BAS) to assess the skills in breaking bad news. Br J Cancer . 1999; 80(5/6): 792-800.

Braybrooke J, Houlbrook S, Crawley JE, Propper DJ, O’ Byrne KJ, Stratford IJ, Shuker DE, Harris AL and Talbot DC. Evaluation of the alkaline comet assay and urine 3-methyl adenine excretion for monitoring DNA damage in melanoma patients treated with dacarbazine and tamoxifen. Cancer Chemother. Pharmacol. 2000; 45: 111-119.

Talbot DC, Moiseyenko V, Van Belle S, et al Randomised, phase II trial comparing oral capecitabine (Xeloda ®) with paclitaxel in patients with metastatic/advanced breast cancer pretreated with anthracyclines. Br J Cancer . 2002; 86: 367-1372.